PHYRAGO
NDC 70709-153, dasatinib, tablet, from Cycle Pharmaceuticals Ltd.
- Product NDC
- 70709-153
- Status
- Listed
- Labeler
- Cycle Pharmaceuticals Ltd
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA216099
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70709-153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB70 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70709-153-70 | 70709015370 | 60 TABLET in 1 BOTTLE (70709-153-70) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/60976d1e-c415-417f-8168-4e07999a7281
Use it
Look up 70709-153 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70709-153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70709-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.